Huajin Capital engages in equity investment, asset management, physical, and incubator.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Huajin Capital engages in equity investment, asset management, physical, and incubator.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2022 | HAAWKING | Series A | 0 |
9/2017 | Das Security | Venture Round | 7.5M |
2/2022 | Sunwoda Electronic | Post-IPO Equity | 0 |
6/2023 | Eccogene | Series B | 0 |
6/2020 | Kingsware | Series A | 14.7M |
3/2019 | Insta360 | Series C | 0 |
1/2023 | Genepoint Biological Technology | Series D | 29.5M |
3/2021 | MingMed | Series A | 0 |
12/2021 | Guizhou Core Long March Technology (Marching Power) | Series C | 78.5M |
2/2022 | Cygnus Semi | Series A | 100M |
6/2020 | MabPlex International | Series B | 0 |
4/2020 | Mabwell Biotech | Series A | 0 |
4/2022 | Beilai Bio | Series B | 47.1M |
10/2019 | Suzhou Kintor Pharmaceuticals | Series D | 0 |
9/2022 | Vivolight | Series D | 14.3M |
1/2023 | Aiste | Venture Round | 44.3M |
4/2022 | Beilai Bio | Series B | 0 |
2/2022 | Sunwoda Electronic | Post-IPO Equity | 0 |
2/2022 | Cygnus Semi | Series A | 0 |
12/2021 | Guizhou Core Long March Technology (Marching Power) | Series C | 0 |
3/2021 | MingMed | Series A | 0 |
6/2020 | MabPlex International | Series B | 0 |
6/2020 | Kingsware | Series A | 0 |
4/2020 | Mabwell Biotech | Series A | 0 |
10/2019 | Suzhou Kintor Pharmaceuticals | Series D | 0 |
3/2019 | Insta360 | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|